NCT03157622

Brief Summary

Exploration of treatment processes during exposure and cognitive-behavioral therapy in the context of chronic low back pain in a multiple baseline single-case design.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2015

Completed
1.5 years until next milestone

First Posted

Study publicly available on registry

May 17, 2017

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

July 5, 2017

Status Verified

July 1, 2017

Enrollment Period

2 years

First QC Date

November 10, 2015

Last Update Submit

July 3, 2017

Conditions

Keywords

Chronic Low Back PainCognitive-Behavioural TherapyExposureTherapeutic processesSingle-case study

Outcome Measures

Primary Outcomes (1)

  • Therapeutic changes during the course of treatment compared to baseline

    Specifically developed questionnaire on therapeutic change processes

    from baseline phase (1-3 weeks) to intervention phase (5 weeks)

Secondary Outcomes (9)

  • Pain severity at posttest and follow-up compared to baseline pain severity

    from pretest (admission) to posttests (an expected average of 8 weeks after admission) to follow-up (an expected average of 6 months after completion)

  • Pain-related anxiety at posttest and follow-up compared to baseline pain-related anxiety

    from pretest (admission) to posttests (an expected average of 8 weeks after admission) to follow-up (an expected average of 6 months after completion)

  • Pain catastrophizing thoughts at posttest and follow-up compared to baseline pain catastrophizing thoughts

    from pretest (admission) to posttests (an expected average of 8 weeks after admission) to follow-up (an expected average of 6 months after completion)

  • Perceived harmfulness of daily activities at posttest and follow-up compared to baseline perceived harmfulness of daily activities

    from pretest (admission) to posttests (an expected average of 8 weeks after admission) to follow-up (an expected average of 6 months after completion)

  • Pain-related avoidance behavior at posttest and follow-up compared to baseline pain-related avoidance behavior

    from pretest (admission) to posttests (an expected average of 8 weeks after admission) to follow-up (an expected average of 6 months after completion)

  • +4 more secondary outcomes

Study Arms (2)

Exposure in vivo

ACTIVE COMPARATOR

In the Exposure in vivo (EXP) condition, patients are given a careful explanation of the fear-avoidance model. Patients are encouraged to adopt the model to their individual situation. Factors for the maintenance of chronic pain (such as pain cognitions and pain-related fear) are discussed. Especially, negative consequences of avoidance behavior are highlighted. In preparation of the exposure sessions, patients develop an individual fear hierarchy using the Photo Series of Daily Actives. Subsequently, patients are encouraged to test their fear-avoidance beliefs during behavioral experiments and to reduce avoidance behaviors during individually tailored exposure exercises.

Behavioral: Exposure in vivo

Cognitive Behavioral Psychotherapy

ACTIVE COMPARATOR

In the Cognitive Behavioral Psychotherapy (CBT) condition, patients are introduced to several strategies to improve their pain management. The principle of graded activity encourages patients to re-engage in former activities by dividing these activities into smaller steps. Predetermined resting periods are offered as a form to prevent patients from phases of excessive demands followed by long terms of recovery. Progressive muscle relaxation is introduced as a technique to improve the experience of pain. The strategy of attention shifting is presented to change their perception of pain. Maladaptive pain-related cognitions are identified and challenged by cognitive interventions.

Behavioral: Cognitive Behavioural Psychotherapy

Interventions

10 sessions based on an individualized fear hierarchy

Exposure in vivo

graded activity, relaxation techniques and cognitive interventions

Cognitive Behavioral Psychotherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 6 months chronic low back pain
  • Sufficient level on fear avoidance scores (PCS \> 35, PASS \>20, QBPDS \> 30, PDI \> 20 and Phoda harm ratings of 13 activities \> 50, including 8 \> 80)
  • German-speaking
  • Agreeing to participate, verified by completion of informed consent

You may not qualify if:

  • Red flags
  • Pregnancy
  • Illiteracy
  • Psychoses
  • Alcohol addiction
  • Surgeries during the last 6 months or planed surgeries
  • Specific medical disorders or cardiovascular diseases preventing participation in physical exercise
  • Participating in another psychotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Philipps University Marburg, Department of Clinical Psychology and Psychotherapy

Marburg, 35037, Germany

Location

Related Links

Study Officials

  • Julia Anna Glombiewski

    Philipps-University Marburg, Departement of Clinical PSychology and Psychotherapy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Julia A. Glombiewski

Study Record Dates

First Submitted

November 10, 2015

First Posted

May 17, 2017

Study Start

June 1, 2015

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

July 5, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations